DataMeds AI (MEDS) Operating Expenses (2024 - 2026)

DataMeds AI (MEDS) has reported Operating Expenses for 3 consecutive years, with $6.2 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 80.69% year-over-year to $6.2 million; the trailing twelve-month figure through Mar 2026 stood at $61.5 million (up 54.16% YoY), and the FY2025 full-year result was $87.3 million, up 1003.61% from the prior year.
• Operating Expenses fell to $6.2 million in Q1 2026 per MEDS's latest filing, from $17.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $32.0 million in Q1 2025 and bottomed at $79764.0 in Q1 2024.
• Historically, Operating Expenses has averaged $11.3 million across 3 years, with a median of $6.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Operating Expenses soared 40069.76% in 2025, then tumbled 80.69% in 2026.
• Over 3 years, Operating Expenses stood at $5.0 million in 2024, then surged by 250.19% to $17.5 million in 2025, then sank by 64.65% to $6.2 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $6.2 million, $17.5 million, and $31.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.